Two Sigma Advisers’s PAVmed PAVM Stock Holding History

Two Sigma Advisers’s Portfolio PAVM Stock Details PAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,334	Closed	-$792K	–	2826
2022 Q1	$792K	Sell	1,334 -1,992	-60%	-$1.48M	﹤0.01%	1768
2021 Q4	$3.68M	Buy	+3,326	New	+$7.23M	0.01%	908

Other funds holding PAVM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Advisers's PAVM Position: Q2 2022 in Review

Two Sigma Advisers sold out of PAVmed (PAVM) in Q2 2022, closing a stake of 1,334 shares — an estimated $792K sold.

Two Sigma Advisers first reported a position in PAVM in Q4 2021 and held it in 2 quarters. The position peaked at $3.68M in Q4 2021. 73 funds tracked by Wall St. Rank hold PAVM as of Q2 2022.

Two Sigma Advisers reported no remaining PAVmed position as of Q2 2022 after selling out during the quarter.
Two Sigma Advisers sold 1,334 PAVmed shares in Q2 2022, an estimated $792K.
Two Sigma Advisers first reported a position in PAVmed in Q4 2021 and held it in 2 quarters.
Two Sigma Advisers's PAVmed position peaked at $3.68M in Q4 2021.
73 funds tracked by Wall St. Rank held PAVmed as of Q2 2022.

Based on Two Sigma Advisers's 13F filing for Q2 2022, filed 15 Aug 2022.